Artificial Intelligence in Healthcare Market

The report "Artificial Intelligence (AI) in Healthcare Market by Function (Imaging, Robotics, AI Scribe, Telehealth, CDS, Precision Medicine, Radiation, RCM, Cybersecurity), Tools (ML, NLP, Computer Vision), End User (Hospital, ASC, Payer) - Global Forecast to 2031" is projected to reach USD 194.79 billion by 2031 from USD 36.67 billion in 2026, at a CAGR of 39.7% during the forecast period.

Browse 455 market data Tables and 54 Figures spread through 738 Pages and in-depth TOC on "Artificial Intelligence (AI) in Healthcare Market, By Function (Imaging, Robotics, AI Scribe, Telehealth, CDS, Precision Medicine, Radiation, RCM, Cybersecurity), Tools (ML, NLP, Computer Vision), End User (Hospital, ASC, Payer) - Global Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/artificial-intelligence-healthcare-market-54679303.html

The market is driven by increasing investments in digital health, expanding AI adoption across clinical workflows, and supportive government initiatives promoting healthcare innovation. For instance, the European Union's AI Act entered into force to establish a harmonized framework for the safe and trustworthy deployment of AI-enabled medical technologies, while the European Health Data Space (EHDS) became operational in 2025 to facilitate secure access to health data for AI-driven research and innovation. Additionally, the European Commission launched healthcare-focused initiatives under its Apply AI Strategy, including AI-powered screening programs and funding to accelerate AI adoption across healthcare systems, further supporting market growth across the region. Similarly, China is accelerating the deployment of AI across key sectors through its national AI development strategy, and Singapore has introduced AI-focused innovation programs and regulatory to support responsible AI adoption. These initiatives, coupled with increasing AI integration across healthcare, are contributing significantly to the continued expansion of the AI in healthcare market.

By tool, the deep learning subsegment held the largest market share in the artificial intelligence (AI) in healthcare market for machine learning in 2025.

By tool, the artificial intelligence (AI) in healthcare market for machine learning has been bifurcated into deep learning, supervised learning, reinforcement learning, unsupervised learning, and other machine learning technologies. The deep learning segment accounted for the largest share of the artificial intelligence (AI) in healthcare market in 2025. The capability to process vast amounts of unstructured medical data, such as electronic health records (EHR), imaging, and genomics, allows accurate disease diagnosis and prediction. The integration of deep learning into healthcare is significantly boosting the AI in healthcare market, leading to substantial investments in diagnostic tools and predictive analytics. As computational power and data availability continue to grow, deep learning is poised to unlock further advancements, solidifying its role as a key enabler of next-generation healthcare technologies.

By end user, healthcare providers held the largest market share in the artificial intelligence (AI) in healthcare market in 2025.

Based on end users, the AI in healthcare market is segmented into healthcare providers, healthcare payers, patients, and other end users. In 2025, healthcare providers accounted for the largest share of the AI in healthcare market. The large share of this end-user segment can be attributed to hospitals' increasing budgets to improve the quality of care and reduce costs. For example, in 2026, Aultman Health System expanded the deployment of Nabla’s ambient AI solution across hundreds of clinicians through its Oracle Cerner integration to improve clinical documentation efficiency and reduce administrative burden. This reflects the growing utilization of AI by healthcare providers to streamline operations and enhance care delivery.

The Asia Pacific region is expected to experience considerable growth from 2026 to 2031.

Based on region, the artificial intelligence (AI) in healthcare market is segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is projected to experience substantial growth during the forecast period. The Asia Pacific (APAC) region is experiencing substantial growth in the adoption of AI technologies in the healthcare sector, driven by demographic shifts, technological advancements, and increased investment in innovation. For example, in 2026, IHH Healthcare expanded the deployment of AI across its Mount Elizabeth Hospital network in Singapore to enhance patient monitoring, claims processing, workforce management, and clinical operations, demonstrating accelerating AI adoption among healthcare providers across the region.

Key Players

The prominent players operating in the artificial intelligence (AI) in healthcare market include Koninklijke Philips N.V. (Netherlands), Microsoft Corporation (US), Siemens Healthineers AG (Germany), NVIDIA Corporation (US), Epic Systems Corporation (US), GE Healthcare (US), Medtronic (US), Oracle (US), Veradigm LLC (US), Merative (IBM) (US), Google (US), Cognizant (US), Johnson & Johnson (US), and Amazon Web Services, Inc. (US), among others. These companies adopted strategies such as product launches, product updates, expansions, partnerships, collaborations, mergers, and acquisitions to strengthen their market presence in the artificial intelligence (AI) in healthcare market.

Don’t miss out on business opportunities in artificial intelligence (AI) in healthcare market . Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com